392 related articles for article (PubMed ID: 24588504)
41. Iron deposition in the precentral grey matter in patients with multiple sclerosis: a quantitative study using susceptibility-weighted imaging.
Rumzan R; Wang JJ; Zeng C; Chen X; Li Y; Luo T; Lv F; Wang ZP; Hou H; Huang F
Eur J Radiol; 2013 Feb; 82(2):e95-9. PubMed ID: 23079047
[TBL] [Abstract][Full Text] [Related]
42. Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
Young KL; Brandt AU; Petzold A; Reitz LY; Lintze F; Paul F; Martin R; Schippling S
Eur J Neurol; 2013 May; 20(5):803-11. PubMed ID: 23369013
[TBL] [Abstract][Full Text] [Related]
43. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
[TBL] [Abstract][Full Text] [Related]
44. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
Zivadinov R; Leist TP
J Neuroimaging; 2005; 15(4 Suppl):10S-21S. PubMed ID: 16385015
[TBL] [Abstract][Full Text] [Related]
45. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
46. Grey matter atrophy in patients suffering from multiple sclerosis.
Kincses ZT; Tóth E; Bankó N; Veréb D; Szabó N; Csete G; Faragó P; Király A; Bencsik K; Vécsei L
Ideggyogy Sz; 2014 Sep; 67(9-10):293-300. PubMed ID: 25518257
[TBL] [Abstract][Full Text] [Related]
47. 'Timed up and go' and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis.
Lorefice L; Coghe G; Fenu G; Porta M; Pilloni G; Frau J; Corona F; Sechi V; Barracciu MA; Marrosu MG; Pau M; Cocco E
J Neurol; 2017 Nov; 264(11):2201-2204. PubMed ID: 28894919
[TBL] [Abstract][Full Text] [Related]
48. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
[TBL] [Abstract][Full Text] [Related]
49. Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.
Sastre-Garriga J; Pareto D; Rovira À
Neuroimaging Clin N Am; 2017 May; 27(2):289-300. PubMed ID: 28391787
[TBL] [Abstract][Full Text] [Related]
50. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS.
Carone DA; Benedict RH; Dwyer MG; Cookfair DL; Srinivasaraghavan B; Tjoa CW; Zivadinov R
Neuroimage; 2006 Jan; 29(2):505-14. PubMed ID: 16169253
[TBL] [Abstract][Full Text] [Related]
51. Recent developments in imaging of multiple sclerosis.
Poloni G; Minagar A; Haacke EM; Zivadinov R
Neurologist; 2011 Jul; 17(4):185-204. PubMed ID: 21712664
[TBL] [Abstract][Full Text] [Related]
52. Measurement and clinical effect of grey matter pathology in multiple sclerosis.
Geurts JJ; Calabrese M; Fisher E; Rudick RA
Lancet Neurol; 2012 Dec; 11(12):1082-92. PubMed ID: 23153407
[TBL] [Abstract][Full Text] [Related]
53. Clinical impact of early brain atrophy in clinically isolated syndromes.
Pérez-Miralles F; Sastre-Garriga J; Tintoré M; Arrambide G; Nos C; Perkal H; Río J; Edo MC; Horga A; Castilló J; Auger C; Huerga E; Rovira A; Montalban X
Mult Scler; 2013 Dec; 19(14):1878-86. PubMed ID: 23652215
[TBL] [Abstract][Full Text] [Related]
54. [Brain atrophy and neurological impairment in patients with multiple sclerosis].
Prakhova LN; Il'ves AG; Petrov AM; Kataeva GV; Pozdniakov AV; Totolian NA; Stoliarov ID
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):32-7. PubMed ID: 19894311
[TBL] [Abstract][Full Text] [Related]
55. Magnetic resonance imaging in multiple sclerosis.
Napoli SQ; Bakshi R
Rev Neurol Dis; 2005; 2(3):109-16. PubMed ID: 16400309
[TBL] [Abstract][Full Text] [Related]
56. What drives MRI-measured cortical atrophy in multiple sclerosis?
Popescu V; Klaver R; Voorn P; Galis-de Graaf Y; Knol DL; Twisk JW; Versteeg A; Schenk GJ; Van der Valk P; Barkhof F; De Vries HE; Vrenken H; Geurts JJ
Mult Scler; 2015 Sep; 21(10):1280-90. PubMed ID: 25583833
[TBL] [Abstract][Full Text] [Related]
57. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
Minagar A; Toledo EG; Alexander JS; Kelley RE
J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
[TBL] [Abstract][Full Text] [Related]
58. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
[TBL] [Abstract][Full Text] [Related]
59. Pathologic and imaging correlates of cognitive deficits in multiple sclerosis: changing the paradigm of diagnosis and prognosis.
Shi J; Baxter LC; Kuniyoshi SM
Cogn Behav Neurol; 2014 Mar; 27(1):1-7. PubMed ID: 24674960
[TBL] [Abstract][Full Text] [Related]
60. Magnetic resonance imaging of grey matter damage in people with MS.
Filippi M; Valsasina P; Rocca M
Int MS J; 2007 Mar; 14(1):12-21. PubMed ID: 17509248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
